共 203 条
[1]
Hanidziar D(2020)Sedation of mechanically ventilated covid-19 patients: challenges and special considerations Anesth Analg 131 e40-e41
[2]
Bittner EA(2020)Sedating ventilated COVID-19 patients with inhalational anesthetic drugs EBioMedicine 55 102770-343
[3]
Orser BA(2020)Sedation for critically ill patients with COVID-19: which specificities? One size does not fit all Anaesth Crit Care Pain Med 39 341-463
[4]
Wang DS(2020)Sedation, analgesia, and paralysis in covid-19 patients in the setting of drug shortages J Intensive Care Med 30 455-1566
[5]
Lu WY(2013)Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study Eur J Anaesthesiol 46 1563-105
[6]
Payen JF(2020)Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS Intensive Care Med 63 104-195
[7]
Chanques G(2020)Shortage of anesthetics: think of inhaled sedation! J Crit Care 18 189-563
[8]
Futier E(2021)Reflection efficiencies of AnaConDa-S and AnaConDa-100 for isoflurane under dry laboratory and simulated clinical conditions: a bench study using a test lung Expert Rev Med Devices 7 558-925
[9]
Velly L(1995)Remifentanil: a new opioid J Clin Anesth 125 912-121
[10]
Jaber S(2020)COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review Br J Anaesth 125 118-763